Dr. Heather Huet is Vice President, Head of Oncology Portfolio Strategy and Management at Takeda Pharmaceuticals and a member of the Takeda Oncology Business Unit Leadership Team. Heather has two decades of broad drug development experience in oncology, progressing multiple novel biologics and cell therapy programs from target identification to clinical proof of concept.

Prior to joining Takeda, Heather was a member of the executive team of Unum Therapeutics, a public biotechnology company focused on discovery and clinical development of next generation engineered cell therapies. She was responsible for the program leadership of clinical stage product candidates, drove R&D strategy, defined governance structure and established best practices for asset strategy and organizational effectiveness.

Prior to Unum, Heather held scientific leadership positions of increasing responsibility at Biogen and Novartis focused on the discovery and development of novel biologics and cell therapies to treat cancer.

Heather received a B.S. with Honors from the University of Texas at Austin and a PhD in Virology from Harvard University.